Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00429494 · ClinicalTrials.gov registry record · Phase 2

GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients

A Phase 2 study of Amenorrhea and Premature Ovarian Failure, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
Phase 2
Development phase
60
Enrollment target
1
Study location

NCT00429494 is a Phase 2 study of Amenorrhea and Premature Ovarian Failure that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 60 participants, below the 353-participant average among 6 other Amenorrhea trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00429494, a Phase 2 study of Amenorrhea and Premature Ovarian Failure, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
Phase 2
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

Primary Objectives: * To determine the effectiveness of the 3-month depot leuprolide in inducing and maintaining secondary amenorrhea in patients undergo hematopoietic stem cell transplantation. * To determine the incidence of regained ovarian function manifested as spontaneous restoration of menstruation and normalization of hormonal level in patients after transplantation and discontinuation of long-acting leuprolide.

Conditions Studied

Amenorrhea Premature Ovarian Failure Ovarian Function Insufficiency

Interventions

  • DRUG Leuprolide Acetate
  • BEHAVIORAL Questionnaire
  • PROCEDURE Hematopoietic Stem Cell Transplantation

Study Locations (1)

Texas

  • UT MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2002-11
Est. Completion 2011-06
Phase Phase 2

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00429494

The ClinicalTrials.gov registry entry for NCT00429494 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 353-participant average among 6 other Amenorrhea trials with a reported enrollment target (83% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Amenorrhea appearing as the primary indexed condition, and to 3 interventions - of which Leuprolide Acetate is the first listed.

NCT00429494 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00429494 about?

NCT00429494 is a clinical study titled "GnRH Analogue for Ovarian Function Preservation in Hematopoietic Stem Cell Transplantation Patients". Primary Objectives: * To determine the effectiveness of the 3-month depot leuprolide in inducing and maintaining secondary amenorrhea in patients undergo hematopoietic stem cell transplantation. * To determine the incidence of regained ovarian function manifested as spontaneous restoration of menst...

What is the current status of trial NCT00429494?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2002-11. Estimated completion is 2011-06.

What conditions does trial NCT00429494 study?

This clinical trial studies the following conditions: Amenorrhea, Premature Ovarian Failure, Ovarian Function Insufficiency.

What interventions are being tested in trial NCT00429494?

The interventions under investigation include: Leuprolide Acetate (DRUG), Questionnaire (BEHAVIORAL), Hematopoietic Stem Cell Transplantation (PROCEDURE).

Who is sponsoring clinical trial NCT00429494?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00429494 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Amenorrhea

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Amenorrhea

All registered trials for this condition

Premature Ovarian Failure

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.